DEBN Competitors and Similar CompaniesClear all
MDxHealth's competitors and similar companies include Precipio.
 MDxHealth MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis. |  Precipio Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market. | |
Founding Date | Founding Date 2003 | Founding Date 1997 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Herstal, BE HQ Nijmegen, NL Irvine, US Plano, US | Locations Omaha, US HQ Glasgow, GB New Haven, US Omaha, US |
Employees | Employees 252 | Employees 4235% increase |
Valuation ($) | Valuation ($) 93.5 m | Valuation ($) 9.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $107.9m (FY, 2025) | Revenue (est.) $24m (FY, 2025) |
Cost of goods | Cost of goods $36.1m (FY, 2025) | Cost of goods $13.3m (FY, 2025) |
Gross profit | Gross profit $71.8m (FY, 2025) | Gross profit $10.7m (FY, 2025) |
Net income | Net income ($33.5m) (FY, 2025) | Net income ($363k) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 1.1m | Total funding raised $ 1.5m |
For sources of this data, please see the company profile
View Company Profiles
Precipio
HQ
Omaha, US
Employees
42↑ 35% increase
Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.
View company